OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Exosomes as Targeted Delivery Platform of CRISPR/Cas9 for Therapeutic Genome Editing
Li Duan, Kan Ouyang, Jianhong Wang, et al.
ChemBioChem (2021) Vol. 22, Iss. 24, pp. 3360-3368
Closed Access | Times Cited: 64
Li Duan, Kan Ouyang, Jianhong Wang, et al.
ChemBioChem (2021) Vol. 22, Iss. 24, pp. 3360-3368
Closed Access | Times Cited: 64
Showing 1-25 of 64 citing articles:
Exosome engineering in cell therapy and drug delivery
Somayeh Sadeghi, Fahimeh Ramezani Tehrani, Safa Tahmasebi, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 1, pp. 145-169
Open Access | Times Cited: 163
Somayeh Sadeghi, Fahimeh Ramezani Tehrani, Safa Tahmasebi, et al.
Inflammopharmacology (2023) Vol. 31, Iss. 1, pp. 145-169
Open Access | Times Cited: 163
Chondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment
Yujie Liang, Xiao Xu, Limei Xu, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 4866-4878
Open Access | Times Cited: 117
Yujie Liang, Xiao Xu, Limei Xu, et al.
Theranostics (2022) Vol. 12, Iss. 11, pp. 4866-4878
Open Access | Times Cited: 117
Cell-derived nanovesicle-mediated drug delivery to the brain: Principles and strategies for vesicle engineering
Yujie Liang, Zoya Iqbal, Jianping Lu, et al.
Molecular Therapy (2022) Vol. 31, Iss. 5, pp. 1207-1224
Open Access | Times Cited: 87
Yujie Liang, Zoya Iqbal, Jianping Lu, et al.
Molecular Therapy (2022) Vol. 31, Iss. 5, pp. 1207-1224
Open Access | Times Cited: 87
Targeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification
Qisong Liu, Defeng Li, Xiaohua Pan, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 56
Qisong Liu, Defeng Li, Xiaohua Pan, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 56
Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
Xiao Xu, Limei Xu, Caining Wen, et al.
Materials Today Bio (2023) Vol. 22, pp. 100760-100760
Open Access | Times Cited: 51
Xiao Xu, Limei Xu, Caining Wen, et al.
Materials Today Bio (2023) Vol. 22, pp. 100760-100760
Open Access | Times Cited: 51
Exosome for mRNA delivery: strategies and therapeutic applications
Zoya Iqbal, Khurrum Rehman, Ayesha Mahmood, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Zoya Iqbal, Khurrum Rehman, Ayesha Mahmood, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 25
Cell-derived extracellular vesicles for CRISPR/Cas9 delivery: engineering strategies for cargo packaging and loading
Yujie Liang, Zoya Iqbal, Jianhong Wang, et al.
Biomaterials Science (2022) Vol. 10, Iss. 15, pp. 4095-4106
Closed Access | Times Cited: 50
Yujie Liang, Zoya Iqbal, Jianhong Wang, et al.
Biomaterials Science (2022) Vol. 10, Iss. 15, pp. 4095-4106
Closed Access | Times Cited: 50
CRISPR/Cas systems: Delivery and application in gene therapy
Jie Huang, Yitong Zhou, Jie Li, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 49
Jie Huang, Yitong Zhou, Jie Li, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 49
Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
Defeng Li, Qisong Liu, Meifeng Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 38
Defeng Li, Qisong Liu, Meifeng Yang, et al.
Bioengineering & Translational Medicine (2023) Vol. 8, Iss. 3
Open Access | Times Cited: 38
The CRISPR/Cas9 System Delivered by Extracellular Vesicles
Xinglong Zhu, Mengyu Gao, Yongfeng Yang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 984-984
Open Access | Times Cited: 29
Xinglong Zhu, Mengyu Gao, Yongfeng Yang, et al.
Pharmaceutics (2023) Vol. 15, Iss. 3, pp. 984-984
Open Access | Times Cited: 29
CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
Yaoyao Lu, Kelly Godbout, Gabriel Lamothe, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102040-102040
Open Access | Times Cited: 28
Yaoyao Lu, Kelly Godbout, Gabriel Lamothe, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102040-102040
Open Access | Times Cited: 28
Stem cell-derived intestinal organoids: a novel modality for IBD
Cheng‐mei Tian, Meifeng Yang, Haoming Xu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Cheng‐mei Tian, Meifeng Yang, Haoming Xu, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Exosome: A megastar of future cancer personalized and precision medicine
Rajib Dhar, Sukhamoy Gorai, Arikketh Devi, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 24
Rajib Dhar, Sukhamoy Gorai, Arikketh Devi, et al.
Clinical and Translational Discovery (2023) Vol. 3, Iss. 3
Open Access | Times Cited: 24
Plant-derived exosomal nanoparticles: potential therapeutic for inflammatory bowel disease
Defeng Li, Qi Tang, Meifeng Yang, et al.
Nanoscale Advances (2023) Vol. 5, Iss. 14, pp. 3575-3588
Open Access | Times Cited: 23
Defeng Li, Qi Tang, Meifeng Yang, et al.
Nanoscale Advances (2023) Vol. 5, Iss. 14, pp. 3575-3588
Open Access | Times Cited: 23
Extracellular Vesicles as Next-Generation Diagnostics and Advanced Therapy Medicinal Products
Agnieszka Stawarska, Magdalena Bamburowicz‐Klimkowska, Elise Rundén‐Pran, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6533-6533
Open Access | Times Cited: 14
Agnieszka Stawarska, Magdalena Bamburowicz‐Klimkowska, Elise Rundén‐Pran, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6533-6533
Open Access | Times Cited: 14
Extracellular Vesicles: A New Star for Gene Drug Delivery
Man Sun, Huan Zhang, Jiayi Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2241-2264
Open Access | Times Cited: 12
Man Sun, Huan Zhang, Jiayi Liu, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2241-2264
Open Access | Times Cited: 12
Exosomal RNAs and EZH2: unraveling the molecular dialogue driving tumor progression
Ahmed Hussein Zwamel, Adnan Ahmad, Farag M. A. Altalbawy, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Ahmed Hussein Zwamel, Adnan Ahmad, Farag M. A. Altalbawy, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Progress of delivery methods for CRISPR-Cas9
Wu Yang, Jiaqi Yan, Pengzhen Zhuang, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 8, pp. 913-926
Open Access | Times Cited: 30
Wu Yang, Jiaqi Yan, Pengzhen Zhuang, et al.
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 8, pp. 913-926
Open Access | Times Cited: 30
Theranostics aspect of extracellular vesicle in cancer liquid biopsy
Shivani Ravipati, Arghya Nath, Sumitaksha Banerjee, et al.
The Journal of Liquid Biopsy (2024) Vol. 3, pp. 100139-100139
Open Access | Times Cited: 6
Shivani Ravipati, Arghya Nath, Sumitaksha Banerjee, et al.
The Journal of Liquid Biopsy (2024) Vol. 3, pp. 100139-100139
Open Access | Times Cited: 6
Small extracellular vesicles (sEVs)-based gene delivery platform for cell-specific CRISPR/Cas9 genome editing
Sunil Kumar Dubey, Zhe Chen, Yuxiao Jarvan Jiang, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2777-2793
Open Access | Times Cited: 6
Sunil Kumar Dubey, Zhe Chen, Yuxiao Jarvan Jiang, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2777-2793
Open Access | Times Cited: 6
CRISPR/Cas9-based application for cancer therapy: Challenges and solutions for non-viral delivery
Yingqi Lin, Ke-Ke Feng, Jie-Ying Lu, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 727-749
Closed Access | Times Cited: 16
Yingqi Lin, Ke-Ke Feng, Jie-Ying Lu, et al.
Journal of Controlled Release (2023) Vol. 361, pp. 727-749
Closed Access | Times Cited: 16
Enhancement of the therapeutic efficacy of mesenchymal stem cell-derived exosomes in osteoarthritis
Zehao Zhang, Sheng Zhao, Zhaofeng Sun, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 14
Zehao Zhang, Sheng Zhao, Zhaofeng Sun, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 14
Natural components as surface engineering agents for CRISPR delivery
Navid Rabiee
Environmental Research (2023) Vol. 232, pp. 116333-116333
Open Access | Times Cited: 13
Navid Rabiee
Environmental Research (2023) Vol. 232, pp. 116333-116333
Open Access | Times Cited: 13
A targeting delivery system for effective genome editing in leukemia cells to reverse malignancy
Xiaohe Ren, Chang Xu, Lili Li, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 645-656
Closed Access | Times Cited: 19
Xiaohe Ren, Chang Xu, Lili Li, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 645-656
Closed Access | Times Cited: 19
Current understanding of MSC-derived exosomes in the management of knee osteoarthritis
Madhan Jeyaraman, Sathish Muthu, Syed Shehabaz, et al.
Experimental Cell Research (2022) Vol. 418, Iss. 2, pp. 113274-113274
Closed Access | Times Cited: 19
Madhan Jeyaraman, Sathish Muthu, Syed Shehabaz, et al.
Experimental Cell Research (2022) Vol. 418, Iss. 2, pp. 113274-113274
Closed Access | Times Cited: 19
